A detailed history of Cairn Investment Group, Inc. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Cairn Investment Group, Inc. holds 22,344 shares of GILD stock, worth $2.07 Million. This represents 1.04% of its overall portfolio holdings.

Number of Shares
22,344
Previous 22,823 2.1%
Holding current value
$2.07 Million
Previous $1.57 Million 19.6%
% of portfolio
1.04%
Previous 0.91%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 17, 2024

SELL
$66.59 - $83.99 $31,896 - $40,231
-479 Reduced 2.1%
22,344 $1.87 Million
Q2 2024

Aug 06, 2024

SELL
$63.15 - $72.88 $91,567 - $105,676
-1,450 Reduced 5.97%
22,823 $1.57 Million
Q1 2024

Apr 15, 2024

SELL
$71.58 - $87.29 $14,316 - $17,458
-200 Reduced 0.82%
24,273 $1.78 Million
Q4 2023

Feb 14, 2024

BUY
$73.27 - $83.09 $99,280 - $112,586
1,355 Added 5.86%
24,473 $1.98 Million
Q3 2023

Nov 06, 2023

BUY
$73.94 - $80.67 $257,680 - $281,134
3,485 Added 17.75%
23,118 $1.73 Million
Q2 2023

Aug 01, 2023

BUY
$76.01 - $86.7 $56,247 - $64,158
740 Added 3.92%
19,633 $1.51 Million
Q1 2023

Apr 24, 2023

BUY
$77.31 - $88.08 $1,546 - $1,761
20 Added 0.11%
18,893 $1.57 Million
Q4 2022

Jan 11, 2023

BUY
$62.32 - $89.47 $47,425 - $68,086
761 Added 4.2%
18,873 $1.62 Million
Q3 2022

Oct 13, 2022

SELL
$59.54 - $68.01 $198,863 - $227,153
-3,340 Reduced 15.57%
18,112 $1.12 Million
Q2 2022

Jul 28, 2022

BUY
$57.72 - $65.01 $78,787 - $88,738
1,365 Added 6.8%
21,452 $1.33 Million
Q1 2022

Apr 26, 2022

BUY
$57.92 - $72.58 $65,160 - $81,652
1,125 Added 5.93%
20,087 $1.54 Million
Q4 2021

Feb 08, 2022

SELL
$64.88 - $73.64 $89,858 - $101,991
-1,385 Reduced 6.81%
18,962 $1.38 Million
Q3 2021

Nov 09, 2021

BUY
$67.69 - $73.03 $167,532 - $180,749
2,475 Added 13.85%
20,347 $1.42 Million
Q2 2021

Aug 12, 2021

BUY
$63.47 - $69.35 $27,609 - $30,167
435 Added 2.49%
17,872 $1.23 Million
Q1 2021

May 04, 2021

SELL
$60.0 - $68.46 $95,700 - $109,193
-1,595 Reduced 8.38%
17,437 $1.13 Million
Q4 2020

Feb 02, 2021

SELL
$56.65 - $64.55 $4,815 - $5,486
-85 Reduced 0.44%
19,032 $1.11 Million
Q3 2020

Nov 02, 2020

BUY
$62.1 - $78.08 $38,812 - $48,800
625 Added 3.38%
19,117 $1.21 Million
Q2 2020

Jul 21, 2020

SELL
$72.34 - $84.0 $30,021 - $34,860
-415 Reduced 2.19%
18,492 $1.42 Million
Q1 2020

Apr 24, 2020

BUY
$62.63 - $80.22 $652,291 - $835,491
10,415 Added 122.64%
18,907 $1.41 Million
Q4 2019

Jan 30, 2020

BUY
$61.62 - $67.78 $523,277 - $575,587
8,492 New
8,492 $551,000

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $116B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Cairn Investment Group, Inc. Portfolio

Follow Cairn Investment Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cairn Investment Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cairn Investment Group, Inc. with notifications on news.